We are live on ! Find out more
TC

TFS Capital Portfolio holdings

AUM $255M
1-Year Est. Return 32.31%
This Fund
S&P 500
This Quarter Est. Return
-0.66%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$694M
AUM Growth
-$235M
Cap. Flow
-$209M
Cap. Flow %
-30.05%
Top 10 Hldgs %
4.41%
Holding
1,236
New
502
Increased
176
Reduced
298
Closed
257

Top Buys

Rank Stock Value
1
INFI
Infinity Pharmaceuticals, Inc.
INFI
+$2.36M
2
COLL icon
Collegium Pharmaceutical
COLL
+$2.32M
3
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$2.29M
4
HSII
Heidrick & Struggles
HSII
+$2.25M
5
HTCH
HUTCHINSON TECHNOLOGY INC
HTCH
+$2.17M

Top Sells

Rank Stock Value
1
EBS icon
Emergent Biosolutions
EBS
+$5.99M
2
CMC icon
Commercial Metals
CMC
+$5.95M
3
BHE icon
Benchmark Electronics
BHE
+$5.84M
4
UPBD icon
Upbound Group
UPBD
+$5.71M
5
RAIL icon
FreightCar America
RAIL
+$5.51M

Sector Composition

Rank Sector Weight
1 Healthcare 18.04%
2 Industrials 15.17%
3 Technology 12.86%
4 Consumer Discretionary 12.11%
5 Financials 7.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NDP
701
DELISTED
TORTOISE ENERGY INDEPENDENCE FUND, INC.
NDP
$251K 0.04%
2,741
+793
+41% +$64.3K
RP
702
DELISTED
RealPage, Inc.
RP
$251K 0.04%
12,043
-64,955
-84% -$1.29M
ESNT icon
703
Essent Group
ESNT
$6.12B
$250K 0.04%
12,003
-43,137
-78% -$825K
CDR
704
DELISTED
Cedar Realty Trust, Inc
CDR
$250K 0.04%
+5,248
New +$241K
OMED
705
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$250K 0.04%
+24,726
New +$290K
ESRT icon
706
Empire State Realty Trust
ESRT
$969M
$249K 0.04%
14,183
-12,267
-46% -$203K
LPSN icon
707
LivePerson
LPSN
$20.8M
$249K 0.04%
2,834
+1,048
+59% +$86.3K
SIR
708
DELISTED
SELECT INCOME REIT
SIR
$248K 0.04%
24,515
-13,935
-36% -$124K
NNC
709
DELISTED
Nuveen North Carolina Quality Municipal Income Fund
NNC
$247K 0.04%
17,908
+6,376
+55% +$86.1K
MEET
710
DELISTED
The Meet Group, Inc. Common Stock
MEET
$246K 0.04%
86,707
-7,040
-8% -$22.2K
NPO icon
711
Enpro
NPO
$6.95B
$245K 0.04%
4,249
-33,136
-89% -$1.6M
NKTR icon
712
Nektar Therapeutics
NKTR
$2.41B
$244K 0.04%
1,182
-1,291
-52% -$248K
PRGS icon
713
Progress Software
PRGS
$1.59B
$242K 0.03%
10,041
-81,686
-89% -$2.01M
CACQ
714
DELISTED
Caesars Acquisition Company
CACQ
$241K 0.03%
39,395
-35,974
-48% -$202K
AFCO
715
DELISTED
American Farmland Company
AFCO
$241K 0.03%
+38,298
New +$230K
PEO
716
Adams Natural Resources Fund
PEO
$733M
$240K 0.03%
+13,860
New +$224K
NUO
717
DELISTED
Nuveen Ohio Quality Municipal Income Fund
NUO
$240K 0.03%
+15,334
New +$236K
SOR
718
Source Capital
SOR
$371M
$239K 0.03%
+6,720
New +$402K
LION
719
DELISTED
Fidelity Southern Corporation
LION
$238K 0.03%
14,824
-5,317
-26% -$86.9K
GATX icon
720
GATX Corp
GATX
$6.52B
$237K 0.03%
+4,994
New +$213K
PHH
721
DELISTED
PHH Corporation
PHH
$236K 0.03%
18,821
-66,581
-78% -$797K
RNP icon
722
Cohen & Steers REIT and Preferred and Income Fund
RNP
$996M
$234K 0.03%
+12,347
New +$218K
WT icon
723
WisdomTree
WT
$3.01B
$234K 0.03%
+20,459
New +$246K
AEL
724
DELISTED
American Equity Investment Life Holding Company
AEL
$234K 0.03%
+13,923
New +$226K
CORE
725
DELISTED
Core Mark Holding Co., Inc.
CORE
$234K 0.03%
+5,736
New +$220K
27 28
29
30 31

Similar funds

KC
KRV Capital New York $255M AUM 18.27% 1-Year Est. Return
IPC
Independent Portfolio Consultants Boca Raton, Florida $241M AUM 21.8% 1-Year Est. Return
ECPI
Energy Capital Partners III Summit, New Jersey $237M AUM
FRM
Fore Research & Management New York $221M AUM 2.93% 1-Year Est. Return
WFG
Windsor Financial Group Minneapolis, Minnesota $214M AUM 6.66% 1-Year Est. Return
IFB
iAB Financial Bank Fort Wayne, Indiana $204M AUM 19.19% 1-Year Est. Return
KL
Kinsight LLC Birmingham, Alabama $176M AUM 17.21% 1-Year Est. Return
RP
Ridgegate Proprietary Sydney, Australia $154M AUM 25.47% 1-Year Est. Return

TFS Capital's Q1 2016 Portfolio in Review

As of Q1 2016, TFS Capital held 1,236 positions worth $694M, down 25% from $929M the previous quarter. Its ten largest holdings account for 4.4% of the portfolio.

TFS Capital withdrew a net $209M in Q1 2016, closing 257 positions and reducing 298 holdings. Its most notable exit was Benchmark Electronics, an estimated $5.84M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 22% a quarter earlier, followed by Industrials and Technology.

Against the trend, TFS Capital opened a new position in Collegium Pharmaceutical worth $2.31M.

  • TFS Capital's largest Q1 2016 buy was Collegium Pharmaceutical: 127,568 shares worth $2.31M.
  • TFS Capital added most to Infinity Pharmaceuticals, Inc. in Q1 2016, an estimated $2.36M increase.
  • TFS Capital's biggest Q1 2016 reduction was Emergent Biosolutions, cutting an estimated $5.99M.
  • TFS Capital fully exited Benchmark Electronics in Q1 2016, selling an estimated $5.84M.
  • TFS Capital's ten largest holdings make up 4.4% of its $694M portfolio in Q1 2016.
  • TFS Capital opened 502 new positions and closed 257 in Q1 2016.
  • TFS Capital's portfolio value fell 25% quarter-over-quarter to $694M.

Based on TFS Capital's 13F filing for Q1 2016, filed 10 May 2016.